Drug design and repurposing with DockThor‑VS web server focusing on SARS‑CoV‑2 therapeutic targets and their non‑synonym variants

Detalhes bibliográficos
Autor(a) principal: Guedes, Isabella A.
Data de Publicação: 2021
Outros Autores: Costa, Leon S. C., Santos, Karina B. dos, Karl, Ana L. M., Rocha, Gregório K., Teixeira, Iury M., Galheigo, Marcelo M., Medeiros, Vivian, Krempser, Eduardo, Custódio, Fábio L., Barbosa, Helio J. C., Nicolás, Marisa F., Dardenne, Laurent E.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/51130
Resumo: 307634/2019-1 and 306894/2019-0/PCI-LNCC 307634/2019-1 and 306894/2019-0/PCI-LNCC E-26/010.001229/2015 and E-26/210.935/2019/Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro 307634/2019-1 and 306894/2019-0/Conselho Nacional de Desenvolvimento Científico e Tecnológico 307634/2019-1 and 306894/2019-0/Conselho Nacional de Desenvolvimento Científico e Tecnológico
id CRUZ_668f09a673be9e5784f0ee91a7f8ba19
oai_identifier_str oai:www.arca.fiocruz.br:icict/51130
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Guedes, Isabella A.Costa, Leon S. C.Santos, Karina B. dosKarl, Ana L. M.Rocha, Gregório K.Teixeira, Iury M.Galheigo, Marcelo M.Medeiros, VivianKrempser, EduardoCustódio, Fábio L.Barbosa, Helio J. C.Nicolás, Marisa F.Dardenne, Laurent E.2022-02-10T11:37:09Z2022-02-10T11:37:09Z2021GUEDES, Isabella A. et al. Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants. Scientifc Reports, v. 11, p. 1-20, Mar. 2021.2045-2322https://www.arca.fiocruz.br/handle/icict/5113010.1038/s41598-021-84700-0307634/2019-1 and 306894/2019-0/PCI-LNCC 307634/2019-1 and 306894/2019-0/PCI-LNCC E-26/010.001229/2015 and E-26/210.935/2019/Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro 307634/2019-1 and 306894/2019-0/Conselho Nacional de Desenvolvimento Científico e Tecnológico 307634/2019-1 and 306894/2019-0/Conselho Nacional de Desenvolvimento Científico e TecnológicoLaboratório Nacional de Computação Científica. Grupo de Modelagem Molecular em Sistemas Biológicos. Petrópolis, RJ, Brasil.Laboratório Nacional de Computação Científica. Grupo de Modelagem Molecular em Sistemas Biológicos. Petrópolis, RJ, Brasil.Laboratório Nacional de Computação Científica. Grupo de Modelagem Molecular em Sistemas Biológicos. Petrópolis, RJ, Brasil.Laboratório Nacional de Computação Científica. Grupo de Modelagem Molecular em Sistemas Biológicos. Petrópolis, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Nacional da Saúde da Mulher e da Criança. Rio de Janeiro, RJ, Brasil.Laboratório Nacional de Computação Científica. Grupo de Modelagem Molecular em Sistemas Biológicos. Petrópolis, RJ, Brasil.Laboratório Nacional de Computação Científica. Grupo de Modelagem Molecular em Sistemas Biológicos. Petrópolis, RJ, Brasil.Laboratório Nacional de Computação Científica. Grupo de Modelagem Molecular em Sistemas Biológicos. Petrópolis, RJ, Brasil.Fundação Oswaldo Cruz. Presidência. Centro de Informação em Saúde Silvestre. Rio de Janeiro, RJ, Brasil.Laboratório Nacional de Computação Científica. Grupo de Modelagem Molecular em Sistemas Biológicos. Petrópolis, RJ, Brasil.Laboratório Nacional de Computação Científica. Grupo de Modelagem Molecular em Sistemas Biológicos. Petrópolis, RJ, Brasil.Laboratório Nacional de Computação Científica. Laboratório de Bioinformática. Petrópolis, RJ, Brasil.Laboratório Nacional de Computação Científica. Grupo de Modelagem Molecular em Sistemas Biológicos. Petrópolis, RJ, Brasil.The COVID-19 caused by the SARS-CoV-2 virus was declared a pandemic disease in March 2020 by the World Health Organization (WHO). Structure-Based Drug Design strategies based on docking methodologies have been widely used for both new drug development and drug repurposing to find effective treatments against this disease. In this work, we present the developments implemented in the DockThor-VS web server to provide a virtual screening (VS) platform with curated structures of potential therapeutic targets from SARS-CoV-2 incorporating genetic information regarding relevant non-synonymous variations. The web server facilitates repurposing VS experiments providing curated libraries of currently available drugs on the market. At present, DockThor-VS provides ready-for-docking 3D structures for wild type and selected mutations for Nsp3 (papain-like, PLpro domain), Nsp5 (Mpro, 3CLpro), Nsp12 (RdRp), Nsp15 (NendoU), N protein, and Spike. We performed VS experiments of FDA-approved drugs considering the therapeutic targets available at the web server to assess the impact of considering different structures and mutations to identify possible new treatments of SARS-CoV-2 infections. The DockThor-VS is freely available at www.dockthor.lncc.br .engNature Publishing GroupAntiviral Agents / pharmacologyCOVID-19Drug DesignDrug Repositioning / methodsHumansInternetMolecular Docking Simulation / methodsPandemics SARS-CoV-2 / metabolism SARS-CoV-2 / pathogenicityPandemicsMetabolismPathogenicityComputational platforms and environmentsHigh-throughput screeningVirtual drug screeningStructure-based drug designSARS‑CoV‑2COVID-19Drug design and repurposing with DockThor‑VS web server focusing on SARS‑CoV‑2 therapeutic targets and their non‑synonym variantsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83134https://www.arca.fiocruz.br/bitstream/icict/51130/1/license.txt0ab46789d568c4ba27c7b5d29a9fe9c4MD51ORIGINALGuedes_Isabella_etal_IFF_COVID-19_2021.pdfGuedes_Isabella_etal_IFF_COVID-19_2021.pdfapplication/pdf2127913https://www.arca.fiocruz.br/bitstream/icict/51130/2/Guedes_Isabella_etal_IFF_COVID-19_2021.pdff12896272ce9c20a4c807cf04beca07aMD52icict/511302023-02-15 22:07:36.204oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-02-16T01:07:36Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Drug design and repurposing with DockThor‑VS web server focusing on SARS‑CoV‑2 therapeutic targets and their non‑synonym variants
title Drug design and repurposing with DockThor‑VS web server focusing on SARS‑CoV‑2 therapeutic targets and their non‑synonym variants
spellingShingle Drug design and repurposing with DockThor‑VS web server focusing on SARS‑CoV‑2 therapeutic targets and their non‑synonym variants
Guedes, Isabella A.
Antiviral Agents / pharmacology
COVID-19
Drug Design
Drug Repositioning / methods
Humans
Internet
Molecular Docking Simulation / methods
Pandemics SARS-CoV-2 / metabolism SARS-CoV-2 / pathogenicity
Pandemics
Metabolism
Pathogenicity
Computational platforms and environments
High-throughput screening
Virtual drug screening
Structure-based drug design
SARS‑CoV‑2
COVID-19
title_short Drug design and repurposing with DockThor‑VS web server focusing on SARS‑CoV‑2 therapeutic targets and their non‑synonym variants
title_full Drug design and repurposing with DockThor‑VS web server focusing on SARS‑CoV‑2 therapeutic targets and their non‑synonym variants
title_fullStr Drug design and repurposing with DockThor‑VS web server focusing on SARS‑CoV‑2 therapeutic targets and their non‑synonym variants
title_full_unstemmed Drug design and repurposing with DockThor‑VS web server focusing on SARS‑CoV‑2 therapeutic targets and their non‑synonym variants
title_sort Drug design and repurposing with DockThor‑VS web server focusing on SARS‑CoV‑2 therapeutic targets and their non‑synonym variants
author Guedes, Isabella A.
author_facet Guedes, Isabella A.
Costa, Leon S. C.
Santos, Karina B. dos
Karl, Ana L. M.
Rocha, Gregório K.
Teixeira, Iury M.
Galheigo, Marcelo M.
Medeiros, Vivian
Krempser, Eduardo
Custódio, Fábio L.
Barbosa, Helio J. C.
Nicolás, Marisa F.
Dardenne, Laurent E.
author_role author
author2 Costa, Leon S. C.
Santos, Karina B. dos
Karl, Ana L. M.
Rocha, Gregório K.
Teixeira, Iury M.
Galheigo, Marcelo M.
Medeiros, Vivian
Krempser, Eduardo
Custódio, Fábio L.
Barbosa, Helio J. C.
Nicolás, Marisa F.
Dardenne, Laurent E.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Guedes, Isabella A.
Costa, Leon S. C.
Santos, Karina B. dos
Karl, Ana L. M.
Rocha, Gregório K.
Teixeira, Iury M.
Galheigo, Marcelo M.
Medeiros, Vivian
Krempser, Eduardo
Custódio, Fábio L.
Barbosa, Helio J. C.
Nicolás, Marisa F.
Dardenne, Laurent E.
dc.subject.mesh.pt_BR.fl_str_mv Antiviral Agents / pharmacology
COVID-19
Drug Design
Drug Repositioning / methods
Humans
Internet
Molecular Docking Simulation / methods
Pandemics SARS-CoV-2 / metabolism SARS-CoV-2 / pathogenicity
Pandemics
Metabolism
Pathogenicity
topic Antiviral Agents / pharmacology
COVID-19
Drug Design
Drug Repositioning / methods
Humans
Internet
Molecular Docking Simulation / methods
Pandemics SARS-CoV-2 / metabolism SARS-CoV-2 / pathogenicity
Pandemics
Metabolism
Pathogenicity
Computational platforms and environments
High-throughput screening
Virtual drug screening
Structure-based drug design
SARS‑CoV‑2
COVID-19
dc.subject.en.pt_BR.fl_str_mv Computational platforms and environments
High-throughput screening
Virtual drug screening
Structure-based drug design
SARS‑CoV‑2
COVID-19
description 307634/2019-1 and 306894/2019-0/PCI-LNCC 307634/2019-1 and 306894/2019-0/PCI-LNCC E-26/010.001229/2015 and E-26/210.935/2019/Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro 307634/2019-1 and 306894/2019-0/Conselho Nacional de Desenvolvimento Científico e Tecnológico 307634/2019-1 and 306894/2019-0/Conselho Nacional de Desenvolvimento Científico e Tecnológico
publishDate 2021
dc.date.issued.fl_str_mv 2021
dc.date.accessioned.fl_str_mv 2022-02-10T11:37:09Z
dc.date.available.fl_str_mv 2022-02-10T11:37:09Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv GUEDES, Isabella A. et al. Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants. Scientifc Reports, v. 11, p. 1-20, Mar. 2021.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/51130
dc.identifier.issn.pt_BR.fl_str_mv 2045-2322
dc.identifier.doi.none.fl_str_mv 10.1038/s41598-021-84700-0
identifier_str_mv GUEDES, Isabella A. et al. Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants. Scientifc Reports, v. 11, p. 1-20, Mar. 2021.
2045-2322
10.1038/s41598-021-84700-0
url https://www.arca.fiocruz.br/handle/icict/51130
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Nature Publishing Group
publisher.none.fl_str_mv Nature Publishing Group
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/51130/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/51130/2/Guedes_Isabella_etal_IFF_COVID-19_2021.pdf
bitstream.checksum.fl_str_mv 0ab46789d568c4ba27c7b5d29a9fe9c4
f12896272ce9c20a4c807cf04beca07a
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324637381165056